Results 181 to 190 of about 356,562 (324)

Drug-Induced liver injury with hypersensitivity features has a better outcome: A single-center experience of 39 children and adolescents [PDF]

, 2011
Harshad Devarbhavi, Dheeraj Karanth, Prasanna KS, A M. Holmb ck, Mallikarjun Patil   +4 more
openalex   +1 more source

Rolling Ultrasharp Microneedle Spheres Enable Topical Delivery of Biologics Through the Skin

Advanced Healthcare Materials, EarlyView.
Rolling ultraminiaturized microneedle spheres (RUMS), created via two‐photon polymerization, unlock effective and painless topical delivery of messenger RNA (mRNA) and drugs through the skin. By gently forming thousands of microscopic pores, RUMS boost skin permeability by up to 100‐fold.
Theocharis Nikiforos Iordanidis, Argyris Spyrou, Samantha Roudi, Fredrik J. Swartling, Göran Stemme, Samir EL Andaloussi, Niclas Roxhed   +6 more
wiley   +1 more source

Round-table discussion: Drug-induced liver injury

, 2008
Hajime Takikawa, Yousuke Murata, Yoshikazu Murawaki, Gotaro Toda, Minoru Nomoto   +4 more
openalex   +2 more sources

Histological discrimination between autoimmune hepatitis and drug-induced liver injury [PDF]

, 2011
Keiichi Fujiwara, Osamu Yokosuka
openalex   +1 more source

Nanocarrier‐Based Targeting of Pattern Recognition Receptors as an Innovative Strategy for Enhancing Sepsis Therapy

Advanced Healthcare Materials, EarlyView.
This review highlights recent progress in nanocarriers targeting pattern recognition receptors (PRRs), including Toll‐like and NOD‐like receptors, for enhancing the treatment of bacterial sepsis and related complications. These nanomedicines deliver antibiotics and anti‐inflammatory agents while modulating immune responses.
Eman A. Ismail, Vincent O. Nyandoro, Calvin A. Omolo, Thirumala Govender   +3 more
wiley   +1 more source

Molecular Mechanisms of Extracellular Vesicle Biogenesis and Their Impact on the Design of Custom EVs

Advanced Healthcare Materials, EarlyView.
Extracellular vesicles (EVs) are pivotal mediators of intercellular communication and disease, yet the fundamental mechanisms controlling their biogenesis and cargo selection remain unclear. This limitation hinders their diagnostic utility and therapeutic development.
Luís Carvalho Ferraz, Paulo Pereira, João Vasco Ferreira   +2 more
wiley   +1 more source

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

, 2008
Naga Chalasani, Robert J. Fontana, Herbert L. Bonkovsky, Paul B. Watkins, Timothy J. Davern, José Luís Serrano, Hongqiu Yang, James Rochon   +7 more
openalex   +2 more sources

Causality assessment methods in drug induced liver injury: Strengths and weaknesses [PDF]

, 2011
Miren García‐Cortés, Camilla Stephens, M. Isabel Lucena, Alejandra Fernández-Castañer, Raúl J. Andrade   +4 more
openalex   +1 more source

Multienzyme (3‐in‐1)‐Mimicking a Single Nucleobase‐Derived Bionanozyme for Versatile Environmental and Biomedical Applications

Advanced Healthcare Materials, EarlyView.
This study reports the development of bioinspired 2D crystalline Bionanozyme derived from a single nucleobase. It effectively mimics multienzyme activity to detect and remove phenolic pollutants, identify disease biomarkers with high sensitivity, and protect cells from oxidative stress.
Subrat Vishwakarma, Om Shanker Tiwari, Durba Banerjee, Linda J. W. Shimon, Amit Israelstam, Ilia Kaminker, Sudip Mukherjee, Ehud Gazit, Pandeeswar Makam   +8 more
wiley   +1 more source

Mechanisms of drug induced liver injury. [PDF]

Cell Mol Life Sci
Skat-Rørdam J, Lykkesfeldt J, Gluud LL, Tveden-Nyborg P.   +3 more
europepmc   +1 more source